PATRICIA SCHRADER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health SAINT LOUIS, MO NPI 1689022089
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health MO ABBVIE INC. All categories
General Payments — all program years on this page
$6,307.53
- Category: General Payments
- Program years: PY2021–2024
- Record count: 296
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,965.60 across 138 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,965.60 | 138 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,334.75 | 60 |
| Lilly USA, LLC | $235.34 | 11 |
| Biogen, Inc. | $192.85 | 8 |
| PFIZER INC. | $156.71 | 15 |
| UCB, Inc. | $155.87 | 6 |
| EMD Serono, Inc. | $85.35 | 3 |
| JAZZ PHARMACEUTICALS INC. | $67.85 | 2 |
| ARGENX US, INC. | $65.28 | 3 |
| Teva Pharmaceuticals USA, Inc. | $64.32 | 3 |
| CATALYST PHARMACEUTICALS, INC. | $62.82 | 3 |
| Neurelis, Inc. | $61.68 | 3 |
| Alexion Pharmaceuticals, Inc. | $50.55 | 2 |
| Sumitomo Pharma America, Inc. | $49.17 | 2 |
| TG THERAPEUTICS, INC. | $47.74 | 2 |
| Neurocrine BioSciences, Inc. | $47.49 | 2 |
| MDD US Operations, LLC | $43.86 | 2 |
| Vanda Pharmaceuticals Inc. | $39.99 | 1 |
| Genentech USA, Inc. | $33.30 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.31 | 1 |
| GENZYME CORPORATION | $28.41 | 1 |
| Supernus Pharmaceuticals, Inc. | $21.93 | 1 |
| Acerta Pharma LLC | $19.84 | 1 |
| Amgen Inc. | $19.35 | 1 |
| Grifols USA, LLC | $19.05 | 1 |
| ACADIA Pharmaceuticals Inc | $17.95 | 1 |
| Kyowa Kirin, Inc. | $13.84 | 1 |
By program year
Records — PY2024 (138)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.